IP Library Granted Patent US 8,304,548
Granted Patent B2
US 8,304,548 · App. 11/649,299 · Granted Nov 6, 2012

Method for producing 1, 2-dihydropyridine-2-one compound

Assignee: Eisai R&D Management Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,304,548
App. No.
11/649,299
Granted
Nov 6, 2012
Kind
B2
Abstract

The present inventions provide a method for commercially producing a 1,2-dihydropyridine-2-one compound represented by the following formula (III-a) wherein the ring A represents an optionally substituted 2-pyridyl group, the ring B represents an optionally substituted phenyl group, and the ring C represents an optionally substituted phenyl group. Further, the invention provides crystals of 3-(2-cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-one and production processes therefor.

Claims (22)

1. A method for producing a compound represented by formula (III):

wherein A 1 , A 2 , A 3 , A 4 and A 5 are as defined below, or a salt thereof, which comprises reacting a compound represented by formula (1):

wherein each of A 1 , A 2 , A 3 and A 4 , which may be the same or different, is a hydrogen atom, an optionally substituted 6- to 14-membered aromatic hydrocarbon ring group or an optionally substituted 5- to 14-membered heteroaromatic ring group, and X is a leaving group, or a salt thereof with a compound represented by formula (II):

wherein A 5 is an optionally substituted 6- to 14-membered aromatic hydrocarbon ring group or an optionally substituted 5- to 14-membered heteroaromatic ring group; and R1 and R2 are as follows: 1) each of R1 and R2, which may be the same or different, is a hydrogen atom or a C1-6 alkyl group, and 2) the compound of formula (II) may form boroxine (a trimer) when both R1 and R2 are hydrogen atoms, or 3) R1, R2, the oxygen atoms and the boron atom, when taken together, form a 5- or 6-membered ring group optionally substituted by one to four C1-6 alkyl groups, in the presence of a palladium compound, a copper compound, a phosphorus compound and a base.

2. A production method according to claim 1 , wherein each of A 2 and A 4 is a hydrogen atom.

3. A production method according to claim 1 , wherein each of A 1 , A 3 and A 5 is a phenyl group, a pyridyl group, a pyrimidyl group, a thienyl group or a furyl group.

4. A production method according to claim 1 , wherein a compound represented by formula (III-a):

wherein the ring A, ring B and ring C are as defined below, or a salt thereof is produced by reacting a compound represented by formula (I-a):

wherein the ring A is an optionally substituted 2-pyridyl group, the ring B is an optionally substituted phenyl group, and X is a leaving group, or a salt thereof with a compound represented by formula (II-a):

wherein the ring C is an optionally substituted phenyl group; and R1 and R2 are as follows: 1) each of R1 and R2, which may be the same or different, is a hydrogen atom or a C1-6 alkyl group, and 2) the compound of formula (II-a) may form boroxine (a trimer) when both R1 and R2 are hydrogen atoms, or 3) R1, R2, the oxygen atoms and the boron atom, when taken together, form a 5- or 6-membered ring group optionally substituted by one to four C1-6 alkyl groups, in the presence of a palladium compound, a copper compound, a phosphorus compound and a base.

5. A production method according to claim 4 , wherein a compound represented by formula (III-b):

or a salt thereof is produced by reacting a compound represented by formula (I-b):

wherein X is a leaving group, or a salt thereof with a compound represented by formula (II-b):

wherein R1 and R2 are as defined above, in a solvent in the presence of a palladium compound, a copper compound, a phosphorus compound and a base.

6. A production method according to claim 5 , wherein the compound (II-b) is a compound represented by formula (II-b-1), formula (II-b-2), formula (II-b-3) or formula (II-b-4):

7. A production method according to claim 1 , wherein X is a halogen atom, an alkylsulfonyloxy group or an arylsulfonyloxy group.

8. A production method according to claim 1 , wherein the palladium compound is palladium acetate, palladium chloride or palladium hydroxide.

9. A production method according to claim 1 , wherein the phosphorus compound is triphenylphosphine or tri-tert-butylphosphine.

10. A production method according to claim 1 , wherein the copper compound is cuprous bromide, cuprous iodide, cuprous chloride or cuprous acetate.

11. A production method according to claim 1 , wherein the base is cesium carbonate, sodium carbonate or potassium carbonate.

12. A production method according to claim 1 , wherein the copper compound is used in an amount of 0.01 to 0.05 mole per mole of the compound represented by formula (1).

13. A production method according to claim 1 , wherein the reaction is carried out in a solvent and 1,2-dimethoxyethane or toluene is used as the solvent for reaction.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2023
From: EISAI R&D MANAGEMENT CO., LTD.
To: CATALYST PHARMACEUTICALS, INC.
Reel/Frame 062511/0759 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 4, 2007
From: ARIMOTO, ITARU; NAGATO, SATOSHI; SUGAYA, YUKIKO; URAWA, YOSHIO; ITO, KOICHI; NAKA, HIROYUKI; OMAE, TAKAO; KAYANO, AKIO; NISHIURA, KATSUTOSHI
To: EISAI R&D MANAGEMENT CO., LTD.
Reel/Frame 018775/0489 →
Priority Claims (1)
JP 2004-198709 · Jul 6, 2004 · national
Continuity (3)
Continuation In Part PCTJP2005012388 · Jul 5, 2005
Continuation In Part PCTJP2005012364 · Jul 5, 2005
Related Publication 20070142640A1 · Jun 21, 2007